Sarepta’s gene therapy under scrutiny after patient death

by

A patient has died while receiving Elevidys, a gene therapy for Duchenne muscular dystrophy, marking the first known death linked to the treatment.

Leave A Comment

Your email address will not be published. Required fields are marked *